Repair & Recovery · Placeholder catalog data
BBGK80 (Klow)
Also known as BPC-157 + GHK-Cu + TB-500 + KPV
An 80 mg multi-peptide blend combining BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg, and KPV 10 mg in one vial, positioned for investigators studying overlapping repair, fibroblast, barrier, and inflammatory signaling pathways.
255 credits
Ships in 10 business days
Paid from your credit pool at checkout. Bulk quantities discount automatically.
Available variants
Pricing and fulfillment information is placeholder data.
| Amount | SKU | Credits | MSRP | Availability | Margin estimate |
|---|---|---|---|---|---|
| 80 mg | PTS-KLW-80 | 51 credits | $139 | 10 business days | 63% estimate |
Margin estimate treats 1 credit as $1 and compares estimated wholesale credit cost with placeholder MSRP. It excludes shipping, taxes, and other costs.
Buy more, save more
Quantity breaks apply per line item and are deducted automatically at checkout.
| Quantity per line | Discount | Example (80 mg unit) |
|---|---|---|
| 10+ units | 5% off | 10 × 51 credits → 485 credits |
| 25+ units | 10% off | 25 × 51 credits → 1,148 credits |
| 50+ units | 15% off | 50 × 51 credits → 2,168 credits |
| 100+ units | 20% off | 100 × 51 credits → 4,080 credits |
Specifications
- Formula
- Composite blend of BPC-157, GHK-Cu, TB-500, and KPV
- Molecular weight
- 7272.48 g/mol
- Sequence
- BPC-157 (15 aa) · GHK-Cu tripeptide complex · TB-500 fragment · KPV tripeptide
- Purity
- Each component ≥99%
- Appearance
- Lyophilized peptide blend
- Storage
- Store lyophilized at −20 °C, protected from light and moisture
Quality record
COA status
COA listedLot PTS-KLW-2607
Placeholder reference. Verify the active lot before ordering.
Research background
KLOW is a four-component blend built for investigators who want one vial spanning connective tissue repair, fibroblast signaling, extracellular matrix remodeling, and anti-inflammatory pathway work. It combines BPC-157, GHK-Cu, TB-500, and KPV into a single internal reference blend.
Across the underlying literature, BPC-157 has been examined in tendon, ligament, gut, and angiogenic models; GHK-Cu has been studied in fibroblast activation, collagen signaling, and dermal remodeling; Thymosin β4 / TB-500 has been explored in migration and wound-repair models; and KPV has been investigated in inflammatory signaling and epithelial barrier contexts.
Supplied as a research-use-only stack for pathway-combination studies and internal formulation work. Not supplied for human or veterinary use.
Mechanism: The stack is positioned around complementary pathway coverage: BPC-157 for cytoprotective and angiogenic signaling, GHK-Cu for copper-peptide and fibroblast activity, TB-500 for actin-mediated migration and tissue-remodeling signaling, and KPV for anti-inflammatory and epithelial-barrier pathway study.
Research use only
For research use only. Not for human or veterinary use.